Electronic Patient-Reported Outcomes (ePROS) Market
The practice of outsourcing clinical studies with a massive rise in the number of trials and the flourishing pharmaceutical industry with a surge in research and development activities are contributing to the electronic patient-reported outcomes (ePROS) market growth. However, the data privacy and security issues hamper the market growth. Further, the integration of artificial intelligence and machine learning with ePROS platforms is expected to bring new electronic patient-reported outcomes (ePROS) market trends in the coming years.
Integration of Artificial Intelligence and Machine Learning with ePROS Platforms to Bring New Trends in Electronic Patient-Reported Outcomes (ePROS) Market During Forecast Period
EPRO platforms integrate artificial intelligence (AI) and machine learning (ML) to improve data analysis and predictive analytics. Using these technologies, patterns in patient-reported data can be found, allowing for more individualized treatment plans and the early detection of possible health problems. Deeper insights are also obtained by analyzing patient free-text responses using AI-driven natural language processing (NLP). For example, Medable, the digital health platform, and Clario integrate AI with their ePRO solutions to improve patient involvement, data accuracy, and real-time insights in clinical trials. These technological advancements are transforming ePRO systems, making them more efficient, accessible, and a major part of the digital health ecosystem. In August 2023, the next-generation, cutting-edge software platform from assisTek, a Pennsylvania-based Clinical Technology company, was intended to streamline their current ecoa (electronic clinical outcome assessments) and epro (electronic patient-reported outcomes) solutions. This state-of-the-art platform incorporates new features and upgrades, such as a proprietary custom operating system, AI-powered configurator, remote device provisioning for improved reusability, and single sign-on (SSO). Thus, the integration of artificial intelligence and machine learning with ePROS platforms—which offers new capabilities to enhance patient data collection, analysis, and integration—is expected to bring new trends in the electronic patient-reported outcomes (ePROS) market in the coming years.
The geographic scope of the electronic patient-reported outcomes (ePROS) market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), South & Central America (Brazil, Argentina, and Rest of South & Central America), and the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and Rest of the Middle East & Africa). The North America electronic patient-reported outcomes (ePROS) market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for electronic patient-reported outcomes (ePROS). It is one of the most developed countries in North America. The country accounts for the major market share owing to the increasing use of digital health technologies, which helps provide patient-centered care. This involves integrating healthcare services with software and hardware, which can be managed and monitored with the help of apps, wearable devices, and other devices. The growing focus on chronic disease management has increased the demand for ePROs as they allow continuous assessment and timely interventions. As per the article published by the American Society of Clinical Oncology in June 2023, in the US, ePRO inclusion in the Centers for Medicare and Medicaid Innovation’s alternative payment model pilot, the Enhancing Oncology Model, is a sign that ePRO implementation should be a crucial step toward high-quality and transformational cancer care that is likely to foster broader adoption. The surging number of clinical trials in the country is expected to increase the demand for ePROs during the forecast period.
Market players are taking various strategic initiatives such as product launches, product approvals, and collaborations, which are further expected to support the market growth. For instance, in June 2024, Evidation launched MigraineSmart, which is a health engagement experience and symptom tracking program on the Evidation app that harnesses survey data, electronic patient-reported outcomes (ePROs), wearable data, and evidence-based content to make it possible for individuals to better understand and manage their migraines. Therefore, an increase in digital health technologies, a surge in demand for patient-centered care, and a rise in strategic initiatives by market players are expected to fuel the growth of the electronic patient-reported outcomes (ePROs) market in the coming years.
The electronic patient-reported outcomes (ePROS) market in Canada is driven by the rise in the adoption of digital health technologies and the increased use of wearables. The integration of technology in healthcare has resulted in the implementation of the electronic health record (EHR) and generated the demand for telehealth services. The government of Canada has taken initiatives to promote digital health technologies in the country. For instance, in April 2018, under the “Regulatory Review of Drugs and Devices” initiative, Health Canada founded a new division within the Therapeutic Products Directorate’s Medical Devices Bureau. This division allows more targeted pre-market evaluation of digital health technologies to adapt to rapidly changing technologies in digital health as well as respond to growing innovation cycles.
The increasing number of clinical trials in Canada has fueled the demand for ePROs to reduce the paperwork and increase efficiency with the help of technology. According to Innovative Medicines Canada, the country accounts for 3.1% of the global clinical trials. Therefore, the increasing adoption of digital health technologies and the surging number of clinical trials have created a demand for ePROs for efficient monitoring of clinical trials, driving the electronic patient-reported outcomes (ePROS) market.
Electronic Patient-Reported Outcomes (ePROS) Market: Competitive Landscape and Key Developments
OpenClinica LLC, Buddy Healthcare Ltd Oy, Castor, Medable Inc, Assistek, Signant Health, Crucial Data Solutions, Curebase, Y-Prime LLC, Clinical Ink Inc, Medidata Solutions, Veeva Systems Inc, Medrio, and PatientIQ are among the prominent players profiled in the electronic patient-reported outcomes (ePROS) market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. These companies focus on geographic expansions and new product launches to meet the increasing demand from consumers worldwide and diversify their product range in specialty portfolios. Their global presence allows them to serve a large customer base, subsequently facilitating market expansion.
